AI Day1 LLC, 10% Owner at Day One Biopharmaceuticals, Inc. (DAWN), bought 213,724 shares at $14.70 ($3.1M) on 2022-01-19, disclosed to the SEC on 2022-01-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.26 | 43,429 | $619K | 20.0% |
| 2 | $14.26 | 43,429 | $619K | 20.0% |
| 3 | $14.70 | 58,818 | $865K | 27.9% |
| 4 | $14.70 | 58,818 | $865K | 27.9% |
| 5 | $14.73 | 4,615 | $68K | 2.2% |
| 6 | $14.73 | 4,615 |
| $68K |
| 2.2% |
| Total | $14.52 avg | 213,724 | $3.1M | 100% |